Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

The COVID-19 pandemic needs no introduction at present. Only a few treatments are available for this disease, including remdesivir and favipiravir. Accordingly, the pharmaceutical industry is striving to develop new treatments for COVID-19. Molnupiravir, an orally active RdRp inhibitor, is in a phas...

Full description

Bibliographic Details
Main Authors: Mohd. Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Saleh I. Alaqel, Mohammed Kanan Alshammari, Mohammed M. Alshehri, Ahmed Subeh Alshrari, Alreshidi Mateq Ali, Ahmed Muteb Al-shammeri, Bushra Dhuhayyan Alhazmi, Aishah Ali Harshan, Md. Tauquir Alam, Abida
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Molecules
Subjects:
molnupiravir
EIDD-2801
MK-4482
EIDD-1931
patents
SARS-CoV-2
Online Access:https://www.mdpi.com/1420-3049/26/19/5795

Internet

https://www.mdpi.com/1420-3049/26/19/5795

Similar Items